.png){kind=icon}
.png){kind=icon}
Return
Postoperative stereotactic radiotherapy for brain metastases: results from a single-center retrospective analysis
.png){kind=icon}
PRE
AI
E
D
V
B
L
G
C
B
J
Y
M
K
DOI：10.1007/s10585-025-10379-6.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
To evaluate outcomes and prognostic factors in patients with resected brain metastases treated with postoperative SRS/SRT, and to develop a novel overall survival (OS) prognostic model. We retrospectively analyzed 70 patients (72 lesions) treated with postoperative SRS/SRT from July 2017 to May 2024. Outcomes included in-field and out-field intracranial progression-free survival (PFS), OS, and incidence of radionecrosis. Prognostic factors were identified using Cox regression. Recursive Partitioning Analysis (RPA) was used to construct an OS model. Median follow-up was 15.1 months. In-field PFS was 96.2% and 90.2%; Out-field PFS was 69.3% and 64.4% at 1 and 2 years respectively. Prior cranial radiotherapy was associated with worse out-field PFS. OS rates were 67.5% at 1 year, 46.7% at 2 years. ECOG performance status, time from surgery to radiotherapy of ≤ 56 days and biologically effective dose using α/ß of 10 (BED10) ≥ 51 Gy were significant OS predictors. Radionecrosis occurred in 7 patients (10%) with median onset at 25.0 months. The novel RPA model stratified patients into 3 groups: RPA-I (ECOG < 2 & BED10 ≥ 51 Gy; median OS 43.4 months, 95% CI 22.3 months–Not reached), RPA-II (ECOG < 2 & BED10 < 51 Gy; median OS 11.9 months, 95% CI 3 months–19.2 months) and RPA-III (ECOG ≥ 2 regardless of BED10 delivered; median OS 4.1 months, 95% CI 1.2 months – 22.0 months) (p < 0.001). RPA-II and RPA-III had higher death risk compared with RPA-I. This model outperformed existing models after bootstrapping validation. Postoperative SRS/SRT is effective for brain metastases. Appropriate patient selection, timely initiation and sufficient radiation dose improve outcomes. Our novel RPA model offers promising prognostic stratification for guiding treatment decisions.
Keywords:
Brain metastases
Postoperative
Radiosurgery
Hypofractionated stereotactic radiotherapy
Journal
C
IF:
3.2
Papers:
2.4K
Citations:
3.4K
Organization
Cited Papers